NCT02289794View on ClinicalTrials.gov

Vaccine Against Escherichia Coli Infection

PHASE1CompletedINTERVENTIONAL

Enrollment

194

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions

E.Coli Infections

Interventions

BIOLOGICAL

E.coli bioconjugate vaccine

Single dose, intramuscular injection (0.5 mL)

BIOLOGICAL

Placebo

Single dose, intramuscular injection (0.5 mL)

Trial Locations (1)

1211

Hôpitaux Universitaires de Genève, Geneva

Sponsors

Lead Sponsor

All Listed Sponsors

lead

GlycoVaxyn AG

INDUSTRY